Roche’s Biosimilar Losses Could Be Closer To CHF5bn

Management Forecast Risen Since Year Began

 
• By Dean Rudge
  
Roche
Roche's global Pharmaceuticals turnover slipped by 1% at CER and by 6% as reported to CHF34.3bn • Source: Shutterstock

More from Biosimilars

More from Products